US Regulators Pressured to Approve COVID-19 Vaccines after UK’s Decision

The US Government has pressured drug regulators to approve COVID-19 vaccines amid the UK’s move and increasing local cases.

The US Government has questioned and pressured drug regulators to approve COVID-19 vaccines amid the UK’s move and increasing local cases. 

The UK government has recently announced that already approved the Pfizer-BioNTech vaccine and said that it would be rolled out by Dec. 7.

Dr. Stephen Hahn, the commissioner of the Food and Drug Administration (FDA), was recently summoned to the White House to give their reason why they had not yet approved the emergency use of the COVID-19 vaccine developed by Pfizer and Moderna.

The FDA announced that they planned to meet on 10 December to discuss approval for the Pfizer vaccine and on 17 December to discuss Moderna’s.

Moderna and Pfizer have both requested Emergency Use Authorization for their vaccines but the FDA’s approval process for a vaccine is generally considered more complicated than the UK’s because vaccine makers are required to submit raw data for review. 

“F.D.A. is one of the few regulatory agencies in the world that actually looks at the raw data. We are going to do our own analysis,” explained Hahn. 

Once the FDA has approved Pfizer’s authorization, vaccinations could begin within 24 hours after approval.

Moderna said that if they were granted authorization, their vaccine could go into use as early as Dec. 21.

“So, we could be seeing both of these vaccines out and getting into people’s arms before Christmas,” reassured Health Secretary Alex Azar.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.